BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27401736)

  • 1. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
    Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
    BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
    Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
    Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
    Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
    Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
    Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
    Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
    Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X
    J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
    Wang KC; Tsai CP; Lee CL; Chen SY; Chin LT; Chen SJ
    Neuroscience; 2012 Dec; 226():510-6. PubMed ID: 23122444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
    Wang S; Yang T; Wan J; Zhang Y; Fan Y
    Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
    Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
    J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.
    Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X
    Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum uric acid level and related clinical features in neuromyelitis optica].
    You XF; Ye J; Qin W; Zhao WH; Hao YG; Hu WL
    Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):935-8. PubMed ID: 21211206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma interleukin-32 expression in patients with neuromyelitis optica.
    Wang H; Wang K; Wang C; Xu F; Qiu W; Hu X
    J Clin Immunol; 2013 Apr; 33(3):666-70. PubMed ID: 23180362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
    Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R
    Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica.
    Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S
    Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
    Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
    Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible link between elevated serum levels of epithelial cell-derived neutrophil-activating peptide-78 (ENA-78/CXCL5) and autoimmunity in autistic children.
    Mostafa GA; Al-Ayadhi LY
    Behav Brain Funct; 2015 Mar; 11():11. PubMed ID: 25871636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha association with neuromyelitis optica.
    Asgari N; Voss A; Steenstrup T; Kyvik KO; Stenager E; Lillevang ST
    Clin Dev Immunol; 2013; 2013():713519. PubMed ID: 24348680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica.
    Zhang B; Jiang Y; Yang Y; Peng F; Hu X
    Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.
    Michael BD; Elsone L; Griffiths MJ; Faragher B; Borrow R; Solomon T; Jacob A
    Cytokine; 2013 Oct; 64(1):90-6. PubMed ID: 23941778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels epithelial cell-derived neutrophil-activating peptide 78/CXCL5 in periodontitis patients undergoing supportive therapy.
    Lappin DF; Murad M; Sherrabeh S; Ramage G
    J Clin Periodontol; 2011 Oct; 38(10):887-93. PubMed ID: 21770992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.